Aravax
aravax.com.au
Actively hiring
Science & Engineering
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
ASCIA Annual Meeting, 2026
ASCIA Annual Meeting 1 - 4 September 2026 Christchurch, New Zealand View event website
Read more
Report
FDA grants fast track designation to peptide-based peanut immunotherapy
FDA grants fast track designation to peptide-based peanut immunotherapy Healio 24 August 2026 Read news
Read more
Report
FDA grants fast track designation to peptide-based peanut immunotherapy
The FDA has granted fast track designation to PVX108, an immunotherapy comprising seven synthetic peanut-peptide fragments, according to a press release.As Healio previously reported, the peptides in PVX108 (Aravax) represent four immunodominant CD4+ T-ce
Read more
Report
Eight biotech companies in Melbourne you should know about
Eight biotech companies in Melbourne you should know about Labiotech 17 August 2026 Read story
Read more
Report
Report
Pro access
Upgrade to see all 37 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oxford
United Kingdom
Regional office
UK
Oxford, OX4 4GP, United Kingdom